Methods that enhance or mimic adiponectin levels have been shown to be effective therapeutic strategies for improving diabetes control, treatment of insulin resistance, and other metabolic abnormalities associated with T2DM. The gene discussed is ADIPOQ; the disease is diabetes mellitus.